The NIAID Adjuvant Webinar Series is a monthly virtual presentation given on current research relating to vaccine adjuvants. Each month a new speaker is invited to share their findings with the adjuvant research community. The overall goals of the webinar series are to publicize recent developments in the adjuvant field and to encourage collaboration between adjuvant researchers. Webinars take place on the fourth Tuesday of every month from 12:30 – 1:30 p.m. (ET), with a hiatus during the summer and winter.
If you are interested in being invited to attend the NIAID Adjuvant Webinar Series, email a request to Ari Joffe.
Upcoming Webinars
2025
ALF Adjuvants
Mangala Rao, Walter Reed Army Institute of Research
February 25, 2025
Saponin Adjuvants
Zoltan Beck, Desert King International
March 25, 2025
Topic: TBD
TBD
April 22, 2025
Tolerogenic Adjuvants
Christina Cargill, Qrono Inc.
May 27, 2025
Summer Break - June, July & August
2024
Vaccine Adjuvants for Global Health – VFI’s Portfolio of Saponin-based Adjuvants
Celine Lemoine, Vaccine Formulation Institute
January 23, 2024
Precision Vaccines Program adjuvant portfolio
David Dowling, Boston Children’s Hospital
February 27, 2024
ACM-CpG adjuvant
Katherine Schultheis, ACM Biosciences
March 26, 2024
ASP-1, a helminth-derived protein adjuvant
Sara Lustigman, New York Blood Center
April 30, 2024
Blood on Chip in vitro model of IM vaccination
Cyril Guyard, Bioaster Microbiology Technology Institute
May 28, 2024
Summer Break - June, July, and August
Yeast-derived squalene for use in vaccine adjuvants
Chase Kempinski, Enepret
September 24, 2024
TBD
October 22, 2024
Winter Break - November and December
Past Webinars
2023
Adjuvanticity of a novel TLR5 agonist
KyungA Cho, Medispan
November 2, 2023
Securing the Supply Chain in Vaccine Adjuvants – Croda Pharma Adjuvant Systems
Dennis Christensen, Croda Pharma
September 26, 2023
Summer Break - June, July, and August
C-type Lectin Receptor Agonists
Kendal Ryter, University of Montana
May 23, 2023
LTA-1 Adjuvant
Betzi Norton, Tulane University
April 25, 2023
Outer Membrane Vesicles and Mucosal Immunity
Lisa Morici and James McLachlan, Tulane University
March 28, 2023
Consider the Adjuvant: Modifying Adjuvant Properties by Selective Alteration of Signaling Pathways
Dr. Aaron Esser-Kahn, University of Chicago
Feb 28, 2023
Carbohydrate fatty acid monosulphate esters are potent adjuvant molecules.
Dr. Luuk Hilgers, LiteVax BV (Oss, the Netherlands)
January 24, 2023
Winter Break - November and December
2022
Update on BECC-based TLR4 ligands for use as vaccine adjuvants
Robert Ernst, University of Maryland
October 25, 2022
Opportunities to Test Immunomodulatory Compounds in Human Immune Organoids
Lisa Wagar, University of California, Irvine
February 22, 2022
Membrane-anchored Cytokines as Novel Vaccine Adjuvants for the Elderly
Chris Pack, Metaclipse
March 22, 2022
Adjuvant discovery using deep learning on high-dimensional phenomics
Matt Booty, Spring Discovery
April 26, 2022
Adjuvant Properties of the TLR 7/8 agonist 3M-052 in Various Animal Models
Mark Tomai and Chris Fox, 3M and AAHI
May 24, 2022
Summer Break - June, July, and August
Nucleoside-Modified mRNA-LNP Therapeutics
Drew Weissman, University of Pennsylvania
September 27, 2022
MAS-1 Adjuvant / Delivery System
Peter Blackburn, Mercia Pharma Inc.
October 25, 2022
Winter Break - November and December